Sprue-like enteropathy associated with olmesartan in a patient with villous atrophy, HLA-DQ2 genotype and antinuclear antibodies

Sprue-like enteropathy associated with olmesartan in a patient with villous atrophy, HLA-DQ2 genotype and antinuclear antibodies

Bibliographic Details
Main Authors:	Isidro Machado, María Reolid, Fernando Martínez-de-Juan, María del Carmen Lapiedra, Fernanda Maia-de Alcántara
Format:	Article
Language:	English
Published:	Aran Ediciones
Series:	Revista Espanola de Enfermedades Digestivas
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082016001100008&lng=en&tlng=en

Similar Items

Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
by: Marta Eusébio, et al.
Published: (2016-03-01)

Olmesartan-Induced Sprue Like Enteropathy
by: Liliana Carneiro, et al.
Published: (2016-03-01)

Sprue-like enteropathy due to olmesartan
by: Cándido Muñoz-Muñoz, et al.
Published: (2015-10-01)

Olmesartan Associated Sprue-Like Enteropathy and Colon Perforation
by: Mahmoud Abdelghany, et al.
Published: (2014-01-01)

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block
by: Isabel A. Hujoel, et al.
Published: (2016-03-01)

Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
by: Luís Carvalho Lourenço, et al.
Published: (2016-11-01)

Sprue-Like Enteropathy and Liver Injury: A Rare Emerging Association with Olmesartan
by: Mihir Odak MD, et al.
Published: (2021-08-01)

Severe olmesartan-induced sprue-like enteropathy with good corticosteroid treatment response
by: R. Alonso-Beato, et al.
Published: (2020-04-01)

Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea
by: G. Solano-Iturri, et al.
Published: (2018-01-01)

Acute kidney injury secondary to diarrhea caused by “sprue-like” enteropathy associated with olmesartan
by: Lourdes Roca-Argente, et al.
Published: (2017-09-01)

Acute kidney injury secondary to diarrhea caused by “sprue-like” enteropathy associated with olmesartan
by: Lourdes Roca-Argente, et al.
Published: (2017-09-01)

Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use
by: Esteban Sáez-González, et al.

Enteropathy Associated with Olmesartan
by: Bruno Moreira da Silva, et al.
Published: (2016-03-01)

Enteropatía sprue-like secundaria a olmesartán
by: Amaia Campos Ruiz, et al.

Tropical Enteropathy and Tropical Sprue in Rhodesia
by: Thomas, G. E.
Published: (1977)

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
by: Harshal Surendra Mandavdhare, et al.
Published: (2017-07-01)

HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation
by: Hossam Murad, et al.
Published: (2018-05-01)

Severe spruelike enteropathy due to olmesartan
by: Gioia Fiorucci, et al.
Published: (2014-02-01)

Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature
by: Tasha Kulai, et al.
Published: (2016-01-01)

Consumo crónico de olmesartán como causa de enteropatía “sprue-like”
by: Alberto López-Serrano, et al.
Published: (2017-03-01)

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
by: Mónica Martins Teixeira, et al.
Published: (2019-04-01)

Evaluation of a new microarray method for genotyping of HLA-DQ2 and HLA-DQ8 for investigation of celiac disease
by: Hidman, Karin
Published: (2012)

HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia-infected jejunal mucosa.
by: Batman, Philip A., et al.
Published: (2014)

Olmesartan-Induced Enteropathy: A Case of Recurrent Diarrhoea
by: Ana Rita Matos, et al.
Published: (2020-05-01)

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.
by: Sophie Scialom, et al.
Published: (2015-01-01)

Severe spruelike enteropathy and collagenous colitis caused by olmesartan
by: Shiho Kaneko, et al.
Published: (2021-09-01)

Structure of the HLA-DR-DQ-genotype in children with coeliac disease
by: Yu. A. Dmitrieva, et al.
Published: (2020-07-01)

Synchronous Collagenous Sprue and Enteropathy-Type T Cell Lymphoma: Variants of the Same Disease
by: SAC Medlicott, et al.
Published: (2004-01-01)

Human Leukocyte Antigen DQ (HLA‐DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India
by: Balakrishnan S Ramakrishna, et al.
Published: (2021-10-01)

Enteropatía sprue-like grave por olmesartán con buena respuesta a tratamiento esteroideo
by: R. Alonso-Beato, et al.
Published: (2020-04-01)

Spruelike Enteropathy Associated with Olmesartan: An Unusual Case of Severe Diarrhea
by: Stephanie E. Dreifuss, et al.
Published: (2013-01-01)

Absence of HLA-DQ2 and HLA-DQ8 does not exclude celiac disease in Brazilian patients
by: Lorete Maria da Silva Kotze, et al.
Published: (2014-12-01)

The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ
by: Ahmet Basturk, et al.
Published: (2017-12-01)

Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue—A Case Report and Brief Literature Review
by: Claudine Desruisseaux, et al.
Published: (2016-01-01)

Enteropatía sprue-like asociada a olmesartán: causa emergente de diarrea crónica asociada a fármacos
by: G. Solano-Iturri, et al.
Published: (2018-01-01)

Tipificação das especificidades HLA-DR e HLA-DQ
by: Eduardo A. Donadi, et al.
Published: (2000-03-01)

Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study
by: Seng Chan You, et al.
Published: (2019-01-01)

Is celiac disease better identified through HLA-DQ8 than through HLA-DQ2 in Mexican subjects?
by: E. Cerda-Contreras, et al.
Published: (2018-10-01)

Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge
by: Cláudio Martins, et al.
Published: (2016-01-01)

HLA-DR/DQ Genotypes in Kurd Patients with Rheumatoid Arthritis: Relation to Disease Activity
by: Dhia J. Al-Timimi, et al.
Published: (2014-05-01)